Compare STBA & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STBA | ALMR |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1995 | 2026 |
| Metric | STBA | ALMR |
|---|---|---|
| Price | $50.46 | $34.59 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | 235.8K | ★ 299.0K |
| Earning Date | 04-23-2026 | N/A |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 2.35 | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | $4.14 | N/A |
| P/E Ratio | $25.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.38 | $21.58 |
| 52 Week High | $53.50 | $38.54 |
| Indicator | STBA | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 65.56 |
| Support Level | $48.99 | $32.00 |
| Resistance Level | $53.50 | $38.54 |
| Average True Range (ATR) | 0.72 | 2.81 |
| MACD | -0.31 | 0.44 |
| Stochastic Oscillator | 23.03 | 68.10 |
S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.